Internal Medicine, Hematology & Oncology · Little Rock, AR
NPI
1295717189
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8901 Carti Way
Little Rock, AR, 72205
Phone (501) 219-8777
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.3M
329,601 services
Medicare patients, 2024
2,181
Average age 75
Drug cost, 2024
$10.3M
4,497 prescriptions
Company payments, 2025
$19.23
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence A Mendelsohn was code J9271 (injection, pembrolizumab, 1 mg), 27,800 times for 56 patients. In total Lawrence A Mendelsohn billed 329,601 services in 275 codes, and Medicare paid $6.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 27,800 | 56 | $43.50 | $1.2M |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 17,700 | 18 | $0.06 | $977 |
| J9299 Injection, nivolumab, 1 mg | Office | 17,660 | 20 | $24.51 | $433K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 12,731 | 94 | $6.16 | $78K |
| J9267 Injection, paclitaxel, 1 mg | Office | 12,164 | 21 | $0.08 | $977 |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 11,220 | 16 | $0.27 | $3,007 |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 11,100 | 16 | $0.37 | $4,098 |
| J0185 Injection, aprepitant, 1 mg | Office | 9,880 | 41 | $1.34 | $13K |
| J9025 Injection, azacitidine, 1 mg | Office | 9,800 | 15 | $0.30 | $2,919 |
| J0897 Injection, denosumab, 1 mg | Office | 9,060 | 59 | $19.53 | $177K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 8,803 | 209 | $0.09 | $781 |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 6,501 | 63 | $15.82 | $103K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,000 | 14 | $0.11 | $668 |
| 36415 Venipuncture Blood Collection | Office | 5,602 | 1,311 | $8.59 | $48K |
| 85025 Blood Count | Office | 5,505 | 1,213 | $7.55 | $42K |
By year: 2022 $5.5M for 414,426 services; 2023 $5.6M for 373,711 services; 2024 $6.3M for 329,601 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 5,602 | 1,311 | $8.59 | $48K |
| 85025 Blood Count | 5,505 | 1,213 | $7.55 | $42K |
| 80053 Clinical Chemistry | 3,785 | 1,143 | $10.31 | $39K |
| 83615 Clinical Chemistry | 3,260 | 1,121 | $5.89 | $19K |
| 84550 Clinical Chemistry | 2,930 | 1,089 | $4.41 | $13K |
| 82728 Clinical Chemistry | 1,667 | 566 | $13.30 | $22K |
| 82378 Clinical Chemistry | 1,656 | 558 | $18.50 | $31K |
| 82784 Immunoassay | 1,205 | 200 | $9.09 | $11K |
| 86300 Immunoassay | 1,069 | 403 | $20.26 | $22K |
| 88185 Surgical Pathology Examination | 805 | 33 | $15.72 | $13K |
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence A Mendelsohn prescribed most often to Medicare patients was Anastrozole, with 691 prescriptions and refills. In total Lawrence A Mendelsohn wrote 4,497 Medicare prescriptions that cost $10.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 691 | 1,332 | 139 | $11K |
| Letrozole Generic | 211 | 353 | 38 | $4,206 |
| Ondansetron Odt Ondansetron | 182 | 183 | 103 | $3,746 |
| Eliquis Apixaban | 162 | 192 | 25 | $111K |
| Prednisone Generic | 154 | 176 | 51 | $536 |
| Tamoxifen Citrate Generic | 142 | 286 | 33 | $3,561 |
| Gabapentin Generic | 125 | 168 | 32 | $926 |
| Raloxifene Hcl Generic | 114 | 211 | 26 | $3,557 |
| Venclexta Venetoclax | 114 | 123 | 15 | $601K |
| Imbruvica Ibrutinib | 109 | 109 | 13 | $1.7M |
| Potassium Chloride Generic | 99 | 115 | 46 | $833 |
| Prochlorperazine Maleate Generic | 97 | 97 | 69 | $2,179 |
| Allopurinol Generic | 90 | 120 | 24 | $707 |
| Procrit Epoetin Alfa | 86 | 91 | 28 | $259K |
| Exemestane Generic | 85 | 134 | 19 | $8,719 |
Brand drugs: 1,199 claims; generic drugs: 3,287 claims; opioid claims: 218.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence A Mendelsohn $19.23 ($19.23 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $19.23.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $19.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.